Found 8 matching trials
Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002) PHASE3 The primary objective of this study is to evaluate the efficacy of letermov...
Show More Learn More & Join Trial
Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections PHASE3 The purpose of this study is to evaluate the efficacy and the tolerance of ...
Show More Location
Hôpital Necker Enfants Malades
Learn More & Join Trial
Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) PHASE3 The study evaluated the efficacy and safety of letermovir (MK-8228) for the...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients PHASE4 The primary objective of the CLEAR-CMV trial is to evaluate the efficacy of...
Show More Location
University Health Network, Toronto General Hospital
Learn More & Join Trial
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir PHASE3 The investigators' hypothesis is that maternal treatment with Letermovir wi...
Show More Location
Hopital Necker - Enfants malades
Learn More & Join Trial
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation PHASE2 This phase II trial studies how well Triplex vaccine works in preventing cy...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040) PHASE3 The purpose of this study was to evaluate the safety and efficacy of leterm...
Show More Location
City of Hope National Medical Center ( Site 0158)
Learn More & Join Trial
Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients PHASE2 The aim of the study is to find out whether AIC246 is safe and efficacious ...
Show More Location
UCLA Medical Center
Learn More & Join Trial